INS and Insulin resistance: Transplanting the gut microbiota of mice in the semaglutide intervention group to recipient mice can reduce fasting blood glucose and insulin levels, improve insulin resistance, reduce lipid accumulation in white adipose tissue and liver, and regulate levels of lipid metabolism-related factors.